Equities

NeuroMetrix Inc

NeuroMetrix Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)4.25
  • Today's Change0.09 / 2.16%
  • Shares traded9.18k
  • 1 Year change-62.85%
  • Beta2.2688
Data delayed at least 15 minutes, as of Mar 28 2024 19:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

  • Revenue in USD (TTM)5.90m
  • Net income in USD-6.53m
  • Incorporated2001
  • Employees26.00
  • Location
    NeuroMetrix Inc1000 Winter StreetWALTHAM 02451United StatesUSA
  • Phone+1 (781) 890-9989
  • Fax+1 (302) 636-5454
  • Websitehttps://www.neurometrix.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioSig Technologies Inc141.00k-30.04m6.17m47.00------43.76-4.80-4.800.022-0.13310.03450.028314.843,000.00-723.66-256.06-3,692.44-335.1377.30---20,963.12-23,958.730.2127-------35.15--14.58--77.86--
BIOLASE Inc49.16m-37.62m6.17m157.00------0.1256-37.97-37.9738.540.57261.342.388.68313,146.50-56.30-49.28-115.21-85.8034.0235.27-41.97-50.720.683-6.610.8778--1.451.27-30.39--18.63--
Bioelectronics Corp1.61m-289.82k6.18m9.00------3.84-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Vivos Therapeutics Inc14.50m-15.41m6.43m154.00--125.71--0.4436-14.70-14.7013.470.03841.01--26.5194,175.33-107.34---197.78--60.10---106.27------0.00---5.10---17.53------
Sigyn Therapeutics Inc0.00-4.15m6.73m5.00---------3.82-3.820.00-2.650.00----0.00-1,266.54-493.15-----------10,223.960.0189-1.20---------41.51------
Sonendo Inc43.87m-60.92m7.08m216.00--0.2369--0.1613-0.6485-0.64850.46670.44720.40722.388.06203,078.70-56.55---74.56--28.05---138.88--1.53-17.040.568--5.30---6.78------
ADM Tronics Unlimited Inc2.85m-716.86k7.08m7.00--6.42--2.49-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Heart Test Laboratories Inc18.60k-6.39m7.66m12.00--0.8613--412.05-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
Vapotherm Inc68.67m-58.19m8.18m182.00------0.1191-9.88-9.8811.38-8.970.79021.446.95377,302.20-66.96-49.73-86.11-62.5441.2743.56-84.74-78.991.23-1.982.07--2.8010.1448.62---10.38--
Neurometrix Inc5.90m-6.53m8.44m26.00--0.3226--1.43-6.29-6.295.6713.180.25611.2310.13226,977.70-28.33-23.24-29.85-27.2666.8959.17-110.64-48.8815.55--0.00---28.52-18.18-47.84--5.03--
Encision Inc6.87m-448.00k8.83m31.00--4.03--1.29-0.0381-0.03810.58350.18631.641.967.84221,520.00-10.69-1.07-14.05-1.4650.5452.27-6.52-0.6131.08-6.220.1123---4.17-3.44-393.90--12.89--
Fuse Medical Inc18.40m3.63m8.87m31.003.34--2.400.48180.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Arch Therapeutics Inc115.33k-7.86m9.30m8.00------80.60-4.07-4.070.0509-2.020.06520.0613--14,416.25-444.57-188.28---804.6327.04---6,819.08-26,945.920.042-2.02----383.83---32.35---21.76--
Prosomnus Inc25.61m-15.02m9.33m129.00------0.3644-0.942-0.9421.52-1.331.2011.868.85198,496.50-70.44---164.95--52.38---58.65--1.38-3.152.57--37.79---19.54------
Nexalin Technology Inc128.63k-4.60m10.20m6.00--3.22--79.31-0.6252-0.62520.01760.43520.02010.175910.3621,438.33-71.92---95.70--78.76---3,574.38--3.43--0.1338--817.17--72.07------
Predictive Oncology Inc1.81m-18.42m10.36m31.00--0.8828--5.73-4.64-4.640.4542.890.07051.164.1658,340.00-71.79-103.24-84.34-147.9970.1365.91-1,018.76-1,439.043.14--0.0219--5.9718.12-30.93--53.80--
Data as of Mar 28 2024. Currency figures normalised to NeuroMetrix Inc's reporting currency: US Dollar USD

Institutional shareholders

10.49%Per cent of shares held by top holders
HolderShares% Held
Cerity Partners LLCas of 31 Dec 202330.00k2.79%
Renaissance Technologies LLCas of 31 Dec 202323.43k2.18%
Topline Capital Management LLCas of 31 Dec 202218.08k1.68%
The Vanguard Group, Inc.as of 31 Dec 202315.12k1.41%
Virtu Americas LLCas of 31 Dec 202312.11k1.13%
Osaic Wealth, Inc. (Investment Management)as of 31 Dec 20236.78k0.63%
BlackRock Fund Advisorsas of 31 Dec 20235.07k0.47%
Tower Research Capital LLCas of 31 Dec 20231.04k0.10%
Accent Capital Management LLCas of 31 Dec 2023625.000.06%
Tucker Asset Management LLCas of 31 Dec 2023402.000.04%
More ▼
Data from 31 Dec 2023 - 18 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.